Cardiac Engineering: The Cardiac Engineering lab develops and test medications, devices, and surgical techniques to reduce perioperative cardiovascular risk.
Art Wallace, M.D., Ph.D.’s research at UCSF has included numerous projects in animals and patients including both device development for surgical therapy of heart failure and the off pump CABG, as well as drug testing. He is best known for his work testing drugs for the prevention of perioperative cardiac morbidity and mortality. He was one of the developers of perioperative beta blockade and has assisted more than 150 hospitals set up perioperative beta blocker programs. His present work includes development of a medications to reduce perioperative cardiac risk, development of the ECOM cardiac output monitor, testing and development of surgical therapies for heart failure, implementation of perioperative beta blockade, developing therapies to prevent perioperative and ICU related PTSD, and developing computer systems to improve systems based medicine. He lectures extensively on cardiac risk reduction and has produced an on-line course on cardiac risk reduction.